Women...Take Your Health to Heart

January 2005
Orange County Business Journal;1/17/2005, Vol. 28 Issue 3, pA-21
Presents a research from the American Heart Association showing cardiovascular disease as the leading cause of death in the U.S. Ability of men and women to reduce the risk of heart disease and stroke through modest lifestyle changes; Need to adopt healthy eating habits and daily physical activity; Recommendations for heart health. INSETS: Power of Red at Neiman Marcus;Hoag Heart Month Classes.


Related Articles

  • Repair of atrioventricular valve regurgitation in the modified Fontan operation. Sallehuddin, Ahmad; Bulbul, Ziad; Otero, Frank; Al Dhafiri, Khaled; Al-Halees, Zohair // European Journal of Cardio-Thoracic Surgery;Jul2004, Vol. 26 Issue 1, p54 

    Objective: To evaluate the prevalence, impact and outcome of repair of atrioventricular valve regurgitation (AVVR) in Fontan patients. Methods: We retrospectively reviewed 340 Fontan patients from 1986 to 2001. Twelve patients with valve closure or replacements were excluded. AVVR was graded by...

  • IMAGES IN CARDIOLOGY: Arrhythmogenic right ventricular cardiomyopathy. John, A. S.; Mohiaddin, R. H.; Sheppard, M. N. // Heart;Sep2004, Vol. 90 Issue 9, p1102 

    Images of a previously fit 24 year old man, who was found struggling for breath, are given in the article . He collapsed and died. He had no significant past medical history, and there was no family history of sudden death. Panel B shows a macroscopic short axis slice of the heart, where yellow...

  • Impact of Candesartan on Nonfatal Myocardial Infarction and Cardiovascular Death in Patients With Heart Failure. Demers, Catherine; McMurray, John J. V.; Swedberg, Karl; Pfeffer, Marc A.; Granger, Christopher B.; Olofsson, Bertil; McKelvie, Robert S.; Östergren, Jan; Michelson, Eric L.; Johansson, Peter A.; Wang, Duolao; Yusuf, Salim // JAMA: Journal of the American Medical Association;10/12/2005, Vol. 294 Issue 14, p1794 

    Context Angiotensin-converting enzyme (ACE) inhibitors reduce the risk of myocardial infarction (MI), but it is not known whether angiotensin receptor blockers have the same effect. Objective To assess the impact of the angiotensin receptor blocker candesartan on MI and other coronary events in...

  • Haemoglobin A1c concentrations were associated with increased cardiovascular disease and all cause mortality. Sigal, Ronald J. // Evidence Based Medicine;Apr2005, Vol. 10 Issue 2, p57 

    The article discusses as to what is the relation between haemoglobin concentrations and coronary heart disease (CHD) events, cardiovascular disease (CVD) events, and all cause mortality. It was found out that persons with known or undiagnosed diabetes had a greater risk of all cause mortality...

  • A Validated Prediction Model for All Forms of Acute Coronary Syndrome: Estimating the Risk of 6-Month Postdischarge Death in an International Registry. Eagle, Kim A.; Lim, Michael J.; Dabbous, Omar H.; Pieper, Karen S.; Goldberg, Robert J.; Van de Werf, Frans; Goodman, Shaun G.; Granger, Christopher B.; Steg, P. Gabriel; Gore, Joel M.; Budaj, Andrzej; Avezum, Álvaro; Flather, Marcus D.; Fox, Keith A. A. // JAMA: Journal of the American Medical Association;6/9/2004, Vol. 291 Issue 22, p2727 

    Context Accurate estimation of risk for untoward outcomes after patients have been hospitalized for an acute coronary syndrome (ACS) may help clinicians guide the type and intensity of therapy. Objective To develop a simple decision tool for bedside risk estimation of 6-month mortality in...

  • Acquired heart conditions in adults with congenital heart disease: a growing problem. Tutarel, Oktay // Heart;Sep2014, Vol. 100 Issue 17, p1317 

    The number of adults with congenital heart disease is increasing due to the great achievements in the field of paediatric cardiology, congenital heart surgery and intensive care medicine over the last decades. Mortality has shifted away from the infant and childhood period towards adulthood. As...

  • Perioperative use of atoravasatin reduced cardiovascular events in patients having vascular surgery.  // ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p64 

    The article addresses the question whether in patients having vascular surgery, perioperative use of atorvastatin reduces cardiovascular events. In patients having vascular surgery, perioperative use of atorvastatin reduced the composite endpoint of cardiovascular events (death from cardiac...

  • Recalibration of the Framingham functions to the Chinese population improved coronary heart disease risk estimates.  // ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p81 

    The article addresses the question how the recalibration of the Framingham functions compares with the performance of the functions derived from the Chinese Multi-provincial Cohort Study [CMCS] for determining the absolute risk for coronary heart disease (CHD) in patients without CHD. The...

  • COMMENTARY: Recalibration of the Framingham functions to the Chinese population improved coronary heart disease risk estimates. Fodor, J. George // ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p81 

    The article presents a commentary on the study, which concluded that recalibration of the Framingham functions to the Chinese population improved coronary heart disease (CHD) risk estimates. The Framingham risk function is the gold standard of global CHD risk evaluation. During the past decade,...

  • C-Reactive Protein and Cardiovascular Disease Risk: Still an Unknown Quantity? Timpson, Nic; Lawlor, Debbie A.; Smith, George Davey // Annals of Internal Medicine;7/4/2006, Vol. 145 Issue 1, p70 

    The author reflects on the risk of C-reactive protein (CRP) and cardiovascular disease. The author has stated that the role of CRP in cardiovascular disease risk has remained controversial. He has stated that higher circulating CRP levels are associated with coronary heart disease (CHD)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics